Failing to find buyer, Fresh Tracks to dissolve, lay off workers

BOULDER — It’s been a wild ride over the past year or so for Fresh Tracks Therapeutics Inc., which plans to dissolve, liquidate and eliminate its workforce after failing to find a buyer or merger partner. 

Last year the drug developer rebranded from Brickell Biotech and sold off rights to its excessive-sweating drug to Botanix Pharmaceuticals Ltd. The company, which has seen its stock price tank in recent years, then began exploring the possibility of a merger or other strategic options for boosting shareholder value, elevated a new CEO and